Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-118226
Filing Date
2025-12-04
Accepted
2025-12-04 06:00:31
Documents
5
Period of Report
2025-12-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2532672d1_6k.htm 6-K 17202
2 EXHIBIT 99.1 tm2532672d1_ex99-1.htm EX-99.1 924474
3 EXHIBIT 99.2 tm2532672d1_ex99-2.htm EX-99.2 203062
4 EXHIBIT 99.3 tm2532672d1_ex99-3.htm EX-99.3 53212
5 GRAPHIC tm2532672d1_ex99-3img001.jpg GRAPHIC 11324
  Complete submission text file 0001104659-25-118226.txt   1214729
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39179 | Film No.: 251548168
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)